Skip to main content
SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD. logo

SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603990 ISIN · CNE100002ZY8 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,647 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603990

About SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD.

https://www.medicalsystem.com.cn/

SUZHOU MEDICAL SYSTEM TECHNOLOGY CO., LTD. specializes in the development and implementation of clinical information systems and digital hospital solutions. The company provides specialized software platforms designed to enhance clinical efficiency and patient safety, including Anesthesia Information Management Systems (AIMS), Intensive Care Unit (ICU) Information Systems, and Emergency Room (ER) Information Systems. Its product portfolio includes digital operating room management solutions and healthcare big data analytics tools that facilitate the integration and management of clinical data across hospital departments. By digitizing clinical workflows, the company enables healthcare institutions to optimize medical processes and improve the quality of patient care through data-driven insights and streamlined information exchange.

Recent filings

Filing Released Lang Actions
关于召开2026年第一季度业绩说明会的公告
Regulatory Filings Classification · 80% confidence The document is a regulatory announcement of an upcoming first-quarter performance explanation meeting (an investor briefing), providing timing, participation methods, and Q&A instructions. It does not contain the actual financial data or presentation itself, nor does it release the report. Therefore, it does not qualify as an Interim/Quarterly Report, Earnings Release, or Investor Presentation. It is a miscellaneous regulatory notification, best classified under Regulatory Filings (RNS).
2026-05-20 Chinese
中汇会计师事务所(特殊普通合伙)关于苏州麦迪斯顿医疗科技股份有限公司非经营性资金占用及其他关联资金往来情况的专项审核说明
Regulatory Filings
2026-03-17 Chinese
麦迪科技关于2026年度公司及控股子公司对外申请融资额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Suzhou Mediston Medical Technology Co., Ltd. regarding the company's and its subsidiaries' application for an external financing quota for the year 2026. It details the amount of financing requested, the types of financing instruments involved, the authorization for the general manager to approve financing agreements within the quota, and the purpose and necessity of the financing. The document is relatively short (1119 characters) and focuses on financing activities rather than presenting financial statements or results. It does not contain financial performance data or detailed financial analysis. Therefore, it is best classified as a Capital/Financing Update (CAP).
2026-03-17 Chinese
麦迪科技关于使用部分闲置募集资金进行现金管理赎回的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Suzhou Mediston Medical Technology Co., Ltd. regarding the use of idle raised funds for cash management and redemption. It details specific transactions involving bank deposits and structured deposits, including amounts, dates, and returns. The document is relatively short (1514 characters) and focuses on the company's cash management activities related to raised funds, not on financial results or comprehensive reports. It is not an annual or interim report, nor an earnings release. It is a specific update on capital usage and cash management, fitting the category of Capital/Financing Update (CAP).
2026-03-17 Chinese
麦迪科技关于未来三年（2026年-2028年）股东分红回报规划的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from Suzhou Mediston Medical Technology Co., Ltd. regarding the company's shareholder dividend return plan for the next three years (2026-2028). It details the company's profit distribution policy, cash dividend conditions, stock dividend conditions, decision-making mechanisms, and adjustment mechanisms. The document is a formal announcement about future dividend policy and planning rather than a report containing financial statements or results. It does not contain actual financial data or results but outlines the company's planned approach to dividends and shareholder returns. The document length is 3096 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best into the category of Notice of Dividend Amount (DIV), as it relates to dividend policy and shareholder returns planning.
2026-03-17 Chinese
麦迪科技关于使用部分闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Suzhou Mediston Medical Technology Co., Ltd. regarding the use of part of idle raised funds for cash management. It details the investment purpose, amount, approval procedures, risk analysis, and impact on the company. The document references regulatory approvals, board resolutions, and compliance with fundraising regulations. It does not contain financial statements or detailed financial performance data but rather focuses on the company's decision and plan to invest idle raised funds in safe, short-term financial products. This type of document is an update on capital/financing activities related to the use of raised funds, not a full financial report or audit. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive information about the financing activity, not just an announcement of a report publication or a certification, so it is not RPA or RNS. Confidence is high due to clear content and context.
2026-03-17 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.